Kollagenaser

Kollagenaser, or collagenases, are proteolytic enzymes that catalyze the selective hydrolysis of collagen, the primary structural protein of the extracellular matrix. They belong to the zinc-dependent metalloprotease family and cleave collagen types I, II, and III, among others, enabling remodeling of connective tissue during development, repair, and normal turnover.

Mechanistically, collagenases are zinc-dependent metalloendopeptidases. The catalytic zinc ion at the active site coordinates a water molecule that acts as a nucleophile to cleave the collagen peptide bonds. Substrate recognition relies on the collagen triple helix, and cleavage typically occurs within the helical region to produce smaller fragments. Activity is tightly regulated by tissue inhibitors of metalloproteinases (TIMPs) to prevent excessive tissue breakdown.

Kollagenaser come from several sources. Mammalian collagenases include MMP-1 (collagenase-1), MMP-8 (neutrophil collagenase), and MMP-13 (collagenase-3), secreted by fibroblasts, neutrophils, and other cells during matrix remodeling. Bacterial collagenases, such as those from Clostridium histolyticum, are widely used in laboratory research and industrial applications for tissue dissociation and certain enzymatic debridement procedures.

Physiological roles include ECM remodeling during development, wound healing, and angiogenesis. Dysregulation is associated with pathology such as osteoarthritis, rheumatoid arthritis, fibrosis, and cancer metastasis, where excessive collagen breakdown can facilitate invasion and alter tissue architecture.

Applications and regulation of kollagenaser span basic research, clinical diagnostics, and therapeutic contexts. They are used for isolating cells from solid tissues and, in some therapies, for enzymatic debridement. Therapeutic approaches aim to balance activity with TIMPs to minimize collateral tissue damage.